Latest On Arena Pharmaceuticals, Inc (ARNA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-03-10 12:30 EST | News | Pfizer confirms HSR waiting period for Arena Pharmaceuticals deal expired | N/A |  |
| 2022-03-09 03:27 EST | News | Arena Pharma ticks higher on Nasdaq delisting notice for Pfizer deal | N/A | |
| 2022-03-08 09:34 EST | News | Arena Pharma gains after report Pfizer deal will clear without HSR second request | N/A | |
| 2022-02-24 08:58 EST | News | Arena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31 | N/A | |
| 2022-02-15 18:44 EST | News | Top Merger Stocks Held By Fund Managers, Mid-Q1 2022 | N/A | |
| 2022-02-01 05:29 EST | News | One of the largest biotech ETFs has the second highest short interest float of U.S. ETFs | N/A | |
| 2021-12-21 16:52 EST | News | Arena Pharmaceuticals reports grants to its 16 new employees | N/A | |
| 2021-12-21 16:52 EST | News | Merger Arbitrage Mondays: Pfizer Acquires Arena Pharmaceuticals At A 100% Premium | N/A | |
| 2021-12-20 22:37 EST | News | Cash Rich Pfizer Splashing $7 Billion On Arena Acquisition Makes Sense - Here's Why | N/A | |
| 2021-12-13 15:40 EST | News | Arena Pharma rockets 95% on acquisition by Pfizer | N/A | |
| 2021-12-13 15:39 EST | News | Why does Pfizer's $6.7B acquisition of Arena Pharmaceuticals make sense? Etrasimod | N/A | |
| 2021-11-20 04:29 EST | News | Arena Pharma achieves target enrollment for etrasimod Cultivate Study A | N/A | |
| 2021-11-05 01:28 EST | News | Arena Pharmaceuticals EPS misses by $0.74 | N/A | |
| 2021-11-05 01:28 EST | News | Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-04 04:17 EST | News | Arena Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-10-18 08:57 EST | News | Warning: ARNA is at high risk of performing badly | N/A | |
| 2021-10-14 14:33 EST | News | Arena Pharmaceuticals: A Speculative Buy To Play The Upcoming Etrasimod's Data-Readout | N/A | |
| 2021-10-07 05:21 EST | News | ARNA is at high risk of performing badly | N/A | |
| 2021-09-27 13:14 EST | News | Warning: ARNA has been downgraded to Very Bearish | N/A | |
| 2021-09-22 21:53 EST | News | Warning: ARNA has been downgraded to Very Bearish. | N/A | |
| 2021-09-09 00:26 EST | News | Small biotechs warn Biden, lawmakers on drug price bill impact on R&D | N/A | |
| 2021-08-06 19:28 EST | News | Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-05 22:21 EST | News | Arena Pharmaceuticals EPS misses by $0.22 | N/A | |
| 2021-08-05 00:00 EST | News | Arena Pharmaceuticals Q2 2021 Earnings Preview | N/A | |
| 2021-07-28 18:02 EST | News | Arena Pharmaceuticals rebounds as Cantor highlights value of deal with Aristea | N/A | |
| 2021-07-28 00:23 EST | News | Arena Pharmaceuticals and Aristea ink RIST4721 collaboration agreement | N/A | |
| 2021-07-20 19:58 EST | News | Arena Pharmaceuticals randomizes first participant in mid-stage temanogrel study | N/A | |
| 2021-07-20 19:58 EST | News | Arena Pharma's etrasimod an Orphan drug in U.S. for eosinophilic esophagitis | N/A | |
| 2021-07-20 19:26 EST | News | Arena Pharmaceuticals names Doug Manion as executive vice president of research & development | N/A | |
| 2021-05-06 07:43 EST | News | Arena Pharmaceuticals EPS beats by $0.20 | N/A | |
| 2021-05-06 07:43 EST | News | Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-05 11:53 EST | News | Arena Pharmaceuticals Q1 2021 Earnings Preview | N/A | |
| 2021-04-27 12:28 EST | News | Cassava, Arena, and Akouos initiated as buys, Cullinan upgraded, and more in today's analyst action | N/A | |
| 2021-04-24 05:39 EST | News | Arena reports positive phase 2 data on etrasimod for atopic dermatitis | N/A | |
| 2021-03-18 04:09 EST | Analyst Rating | The Analyst Target Price has decreased from $94.93 to $93.77. | Neutral | |
| 2021-03-04 07:08 EST | Analyst Rating | The Analyst Target Price has increased from $94.13 to $94.93. | Buy | |
| 2021-03-03 22:26 EST | News | Arena's olorinab flunks mid-stage irritable bowel syndrome study | N/A | |
| 2021-03-03 07:09 EST | Analyst Rating | The Analyst Target Price has decreased from $94.73 to $94.13. | Neutral | |
| 2021-03-03 03:03 EST | News | Arena posts topline results from mid-stage irritable bowel syndrome trial | N/A | |
| 2021-02-25 03:08 EST | Analyst Rating | The Analyst Target Price has decreased from $95.53 to $94.73. | Neutral | |
| 2021-02-24 11:07 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-24 04:14 EST | News | Arena Pharmaceuticals EPS misses by $0.27 | N/A | |
| 2021-02-24 04:13 EST | News | Arena Pharmaceuticals Inc.'s (ARNA) CEO Amit Munshi on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-24 03:08 EST | Earnings Estimate | An EPS average of -$6.75 is estimated for the 2022 year. | Sell | |
| 2021-02-24 03:08 EST | Earnings Estimate | An EPS average of -$2.00 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-02-24 03:08 EST | Analyst Rating | The Analyst Target Price has increased from $95.2 to $95.53. | Buy | |
| 2021-02-23 10:23 EST | News | Arena Pharmaceuticals Q4 2020 Earnings Preview | N/A | |
| 2021-02-02 22:07 EST | News | Arena completes full enrollment of etrasimod phase 3 trial | N/A | |
| 2021-02-01 03:08 EST | Analyst Rating | The Analyst Target Price has increased from $94.79 to $95.2. | Buy | |
| 2021-01-14 01:07 EST | News | Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at 39th Annual J.P. Morgan Healthcare Conference (Transcript) | N/A | |
About Arena Pharmaceuticals, Inc (ARNA):
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase I clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah.
General
- Name Arena Pharmaceuticals, Inc
- Symbol ARNA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 363
- Last Split Factor1:10
- Last Split Date2017-06-19
- Fiscal Year EndDecember
- IPO Date2000-07-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.arenapharm.com
View More
Valuation
- Trailing PE 6.4
- Price/Sales (Trailing 12 Mt.) 13271.13
- Price/Book (Most Recent Quarter) 4.32
- Enterprise Value Revenue 11302.32
- Enterprise Value EBITDA 3.52
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$8.14
- Next Year EPS Estimate -$7.34
- Next Quarter EPS Estimate -$1.92
- Operating Margin -133743%
- Return on Assets -23%
- Return on Equity -38%
- Revenue 319000
- Earnings Per Share $10.84
- Revenue Per Share $0.01
- Gross Profit -323421000
- Quarterly Earnings Growth -98.8%
View More
Highlights
- Market Capitalization 4.4 billion
- EBITDA 549.79 million
- PEG Ratio 0.46
- Analyst Target Price $93.77
- Book Value Per Share $18.44
View More
Share Statistics
- Shares Outstanding 60.33 million
- Shares Float 56.02 million
- % Held by Insiders 19%
- % Held by Institutions 91.89%
- Shares Short 3.48 million
- Shares Short Prior Month 3.42 million
- Short Ratio 7.32
- Short % of Float 6%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 0.73
- 52 Week High $90.19
- 52 Week Low $37.3
- 50 Day Moving Average 78.34
- 200 Day Moving Average 75.25
View More
Dividends
- Dividend Date 2017-06-19
- ExDividend Date N/A
- Dividend Yield 0%
View More
Arena Pharmaceuticals, Inc (ARNA) Dividend Calendar:
ARNA's last dividend payment was made to shareholders on June 19, 2017.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Arena Pharmaceuticals, Inc (ARNA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-23 | $37000 | -$2.10 | -$1.81 | -16.2% |
| 2020-09-30 | 2020-11-09 | $N/A | -$1.69 | -$1.86 | 9.03% |
| 2020-06-30 | 2020-08-05 | $N/A | -$1.61 | -$2.00 | 19.65% |
| 2020-03-31 | 2020-05-07 | $N/A | -$2.00 | -$2.42 | 17.29% |
| 2019-12-31 | 2020-02-26 | $3 million | -$1.76 | -$1.54 | -14.22% |
| 2019-09-30 | 2019-11-07 | $1.35 million | -$1.46 | -$1.31 | -11.46% |
| 2019-06-30 | 2019-08-07 | $1.02 million | -$1.24 | -$1.07 | -15.46% |
| 2019-03-31 | 2019-05-08 | $801.06 million | $12.10 | $14.31 | -15.42% |
| 2018-12-31 | 2019-02-26 | $8.65 million | $1.35 | -$0.73 | 284.96% |
| 2018-09-30 | 2018-11-07 | $3.57 million | -$0.70 | -$0.74 | 5.07% |
| 2018-06-30 | 2018-08-06 | $3.99 million | -$0.65 | -$0.64 | -1.8% |
| 2018-03-31 | 2018-05-08 | $1.76 million | -$0.78 | -$0.64 | -21.34% |
| 2017-12-31 | 2018-03-14 | $273000 | -$0.35 | -$0.57 | 39.16% |
| 2017-09-30 | 2017-11-07 | $7.95 million | -$0.54 | -$0.66 | 18.17% |
| 2017-06-30 | 2017-08-07 | $6.49 million | -$0.77 | -$0.58 | -32.23% |
| 2017-03-31 | 2017-05-09 | $6.62 million | -$0.90 | -$0.85 | -5.68% |
| 2016-12-31 | 2017-03-14 | $85.37 million | $2.48 | -$0.73 | 438.9% |
| 2016-09-30 | 2016-11-07 | $19.24 million | -$0.50 | -$0.65 | 23.85% |
| 2016-06-30 | 2016-08-08 | $9.51 million | -$1.10 | -$0.97 | -13.88% |
| 2016-03-31 | 2016-05-09 | $9.85 million | -$0.90 | -$1.05 | 14.45% |
| 2015-12-31 | 2016-02-29 | $7.75 million | -$1.09 | -$1.28 | 14.69% |
| 2015-09-30 | 2015-11-09 | $9.14 million | -$1.10 | -$1.34 | 17.91% |
| 2015-06-30 | 2015-08-05 | $9.18 million | -$1.10 | -$1.39 | 20.86% |
| 2015-03-31 | 2015-05-11 | $12.26 million | -$0.10 | -$0.14 | 28.57% |
| 2014-12-31 | 2015-03-02 | $9.19 million | -$0.15 | -$0.12 | -25% |
| 2014-09-30 | 2014-11-03 | $8.16 million | -$0.05 | -$0.11 | 54.55% |
| 2014-06-30 | 2014-08-01 | $12.8 million | -$1.20 | -$1.06 | -13.21% |
| 2014-03-31 | 2014-05-12 | $6.81 million | -$1.20 | -$1.04 | -15.38% |
| 2013-12-31 | 2014-02-27 | $6.52 million | -$1.10 | $0.24 | -558.33% |
| 2013-09-30 | 2013-11-07 | $3.58 million | -$0.80 | -$1.16 | 31.03% |
| 2013-06-30 | 2013-08-01 | $68.93 million | $1.80 | $1.53 | 17.65% |
| 2013-03-31 | 2013-05-02 | $2.37 million | -$0.90 | $0.86 | -204.65% |
| 2012-12-31 | 2013-03-04 | $1.94 million | -$1.00 | -$0.28 | -257.14% |
| 2012-09-30 | 2012-11-06 | $1.49 million | -$0.70 | -$0.86 | 18.6% |
| 2012-06-30 | 2012-08-09 | $21.98 million | -$1.20 | -$0.67 | -79.1% |
| 2012-03-31 | 2012-05-01 | $2.19 million | -$1.80 | -$1.25 | -44% |
| 2011-12-31 | 2012-03-14 | $2.08 million | -$1.60 | -$1.49 | -7.38% |
| 2011-09-30 | 2011-11-09 | $3.46 million | -$1.60 | -$1.37 | -16.79% |
| 2011-06-30 | 2011-08-09 | $3.26 million | -$1.60 | -$1.56 | -2.56% |
| 2011-03-31 | 2011-05-10 | $3.93 million | -$3.50 | -$2.11 | -65.88% |
| 2010-12-31 | 2011-03-11 | $4.01 million | -$2.33 | ||
| 2010-09-30 | 2010-11-09 | $7.63 million | -$3.10 | -$2.27 | -36.56% |
| 2010-06-30 | 2010-08-03 | $2.46 million | -$2.80 | -$2.87 | 2.44% |
| 2010-03-31 | 2010-05-07 | $2.51 million | -$3.30 | -$3.16 | -4.43% |
| 2009-12-31 | 2010-03-12 | $2.68 million | -$3.20 | -$3.06 | -4.58% |
| 2009-09-30 | 2009-11-09 | $2.62 million | -$3.80 | -$3.38 | -12.43% |
| 2009-06-30 | 2009-08-03 | $2.43 million | -$4.80 | -$4.85 | 1.03% |
| 2009-03-31 | 2009-05-11 | $2.66 million | -$6.80 | -$6.82 | 0.29% |
| 2008-12-31 | 2009-03-12 | $2.7 million | -$8.40 | -$7.83 | -7.28% |
| 2008-09-30 | 2008-10-30 | $1.86 million | -$7.60 | -$8.32 | 8.65% |
| 2008-06-30 | 2008-08-05 | $2.65 million | -$8.90 | -$7.41 | -20.11% |
| 2008-03-31 | 2008-05-07 | $2.61 million | -$7.50 | -$6.74 | -11.28% |
| 2007-12-31 | 2008-02-27 | $4.57 million | -$6.00 | -$7.84 | 23.47% |
| 2007-09-30 | 2007-10-17 | $5.04 million | -$5.40 | -$7.10 | 23.94% |
| 2007-06-30 | 2007-07-19 | $4.81 million | -$6.40 | -$6.41 | 0.16% |
| 2007-03-31 | 2007-04-18 | $4.91 million | -$5.30 | -$6.70 | 20.9% |
| 2006-12-31 | 2007-02-21 | $4.7 million | -$7.60 | -$9.12 | 16.67% |
| 2006-09-30 | 2006-10-25 | $4.42 million | -$4.30 | -$6.00 | 28.33% |
| 2006-06-30 | 2006-07-25 | $9.33 million | -$4.00 | -$4.35 | 8.05% |
| 2006-03-31 | 2006-05-08 | $12.13 million | -$3.00 | -$4.16 | 27.88% |
| 2005-12-31 | 2006-02-22 | $5.88 million | -$5.50 | -$5.55 | 0.9% |
| 2005-09-30 | 2005-10-17 | $7.43 million | -$4.60 | -$4.89 | 5.93% |
| 2005-06-30 | 2005-07-19 | $5.51 million | -$4.60 | -$4.82 | 4.56% |
| 2005-03-31 | 2005-04-26 | $4.42 million | -$7.90 | -$5.95 | -32.77% |
| 2004-12-31 | 2005-02-16 | $2.12 million | -$7.00 | -$6.23 | -12.36% |
| 2004-09-30 | 2004-10-20 | $4.38 million | -$5.40 | -$6.10 | 11.48% |
| 2004-06-30 | 2004-07-20 | $1.4 million | -$6.70 | -$5.50 | -21.82% |
| 2004-03-31 | 2004-04-20 | $5.78 million | -$4.90 | -$4.20 | -16.67% |
| 2003-12-31 | 2004-01-21 | $1.62 million | -$5.80 | ||
| 2003-09-30 | 2003-10-23 | $2.87 million | -$4.28 | ||
| 2003-06-30 | 2003-08-13 | $2.97 million | -$4.24 | ||
| 2003-03-31 | 2003-04-24 | $5.38 million | -$3.19 | ||
| 2002-12-31 | 2003-01-20 | $6.36 million | -$3.20 | -$4.50 | 28.89% |
| 2002-09-30 | 2002-10-29 | $2.99 million | -$3.70 | -$3.27 | -13.15% |
| 2002-06-30 | 2002-07-23 | $5.83 million | -$2.70 | -$2.46 | -9.76% |
| 2002-03-31 | 2002-04-24 | $4.24 million | -$2.40 | -$1.70 | -41.18% |
| 2001-12-31 | 2002-01-17 | $5.87 million | -$1.00 | -$0.95 | -5.26% |
| 2001-09-30 | 2001-10-18 | $3.47 million | -$0.70 | -$0.59 | -18.64% |
| 2001-06-30 | 2001-07-23 | $3.33 million | -$1.40 | $0.24 | -683.33% |
| 2001-03-31 | 2001-04-17 | $5.39 million | $0.50 | $0.45 | 11.11% |
| 2000-12-31 | 2001-01-18 | $4.08 million | $0.50 | $0.65 | -23.08% |
| 2000-09-30 | 2000-10-25 | $2.31 million | -$0.70 | -$1.13 | 38.05% |
Arena Pharmaceuticals, Inc (ARNA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Arena Pharmaceuticals, Inc (ARNA) Chart:
Arena Pharmaceuticals, Inc (ARNA) News:
Below you will find a list of latest news for Arena Pharmaceuticals, Inc (ARNA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Arena Pharmaceuticals, Inc (ARNA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Arena Pharmaceuticals, Inc (ARNA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/0001564590-20-029991-index.htm |
| 2018-07-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1080709/000000000018022975/0000000000-18-022975-index.htm |
| 2018-08-29 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1080709/000000000018026804/0000000000-18-026804-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000021545719003162/0000215457-19-003162-index.htm |
| 2018-11-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000031506618002492/0000315066-18-002492-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000083423720004717/0000834237-20-004717-index.htm |
| 2020-04-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000083423720009364/0000834237-20-009364-index.htm |
| 2019-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000090221919000007/0000902219-19-000007-index.htm |
| 2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000090221920000112/0000902219-20-000112-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000093247119004497/0000932471-19-004497-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000110465920017921/0001104659-20-017921-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000110465920021671/0001104659-20-021671-index.htm |
| 2020-04-16 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1080709/000114036120009056/0001140361-20-009056-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1080709/000114036120010120/0001140361-20-010120-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1080709/000114036120010124/0001140361-20-010124-index.htm |
| 2020-05-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1080709/000114036120012333/0001140361-20-012333-index.htm |
| 2018-08-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000114420418046461/0001144204-18-046461-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1080709/000114420419008376/0001144204-19-008376-index.htm |
| 2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1080709/000119312518143053/0001193125-18-143053-index.htm |
| 2020-02-27 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1080709/000119312520052902/0001193125-20-052902-index.htm |
| 2020-05-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1080709/000119312520153065/0001193125-20-153065-index.htm |
| 2020-05-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1080709/000119312520154332/0001193125-20-154332-index.htm |
| 2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000119312520154340/0001193125-20-154340-index.htm |
| 2018-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118025436/0001209191-18-025436-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038061/0001209191-18-038061-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038064/0001209191-18-038064-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038068/0001209191-18-038068-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038076/0001209191-18-038076-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038079/0001209191-18-038079-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038083/0001209191-18-038083-index.htm |
| 2018-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118042139/0001209191-18-042139-index.htm |
| 2018-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118042143/0001209191-18-042143-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118047467/0001209191-18-047467-index.htm |
| 2018-12-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118062937/0001209191-18-062937-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919118062940/0001209191-18-062940-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002949/0001209191-19-002949-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002950/0001209191-19-002950-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002951/0001209191-19-002951-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002952/0001209191-19-002952-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002953/0001209191-19-002953-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119007127/0001209191-19-007127-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119018252/0001209191-19-018252-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037485/0001209191-19-037485-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037487/0001209191-19-037487-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037490/0001209191-19-037490-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037492/0001209191-19-037492-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037495/0001209191-19-037495-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037501/0001209191-19-037501-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037506/0001209191-19-037506-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037512/0001209191-19-037512-index.htm |
| 2019-06-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119038322/0001209191-19-038322-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049105/0001209191-19-049105-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053332/0001209191-19-053332-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053333/0001209191-19-053333-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053335/0001209191-19-053335-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053336/0001209191-19-053336-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053337/0001209191-19-053337-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053339/0001209191-19-053339-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119056490/0001209191-19-056490-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919119058166/0001209191-19-058166-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120007531/0001209191-20-007531-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120007535/0001209191-20-007535-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009831/0001209191-20-009831-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009834/0001209191-20-009834-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009837/0001209191-20-009837-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120014125/0001209191-20-014125-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120015567/0001209191-20-015567-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120015576/0001209191-20-015576-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120015583/0001209191-20-015583-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120015590/0001209191-20-015590-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120015597/0001209191-20-015597-index.htm |
| 2020-03-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120015611/0001209191-20-015611-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120019760/0001209191-20-019760-index.htm |
| 2020-03-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120019762/0001209191-20-019762-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120019765/0001209191-20-019765-index.htm |
| 2020-03-18 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120019882/0001209191-20-019882-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034544/0001209191-20-034544-index.htm |
| 2020-06-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037089/0001209191-20-037089-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037092/0001209191-20-037092-index.htm |
| 2020-06-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037093/0001209191-20-037093-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037101/0001209191-20-037101-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037102/0001209191-20-037102-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037103/0001209191-20-037103-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037104/0001209191-20-037104-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037105/0001209191-20-037105-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037106/0001209191-20-037106-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037107/0001209191-20-037107-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037151/0001209191-20-037151-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037654/0001209191-20-037654-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120042910/0001209191-20-042910-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120045483/0001209191-20-045483-index.htm |
| 2020-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048662/0001209191-20-048662-index.htm |
| 2020-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048864/0001209191-20-048864-index.htm |
| 2018-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1080709/000156459018009865/0001564590-18-009865-index.htm |
| 2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018011786/0001564590-18-011786-index.htm |
| 2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459018012393/0001564590-18-012393-index.htm |
| 2018-06-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1080709/000156459018015576/0001564590-18-015576-index.htm |
| 2018-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018015632/0001564590-18-015632-index.htm |
| 2018-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018016709/0001564590-18-016709-index.htm |
| 2018-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018016892/0001564590-18-016892-index.htm |
| 2018-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018019415/0001564590-18-019415-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459018019939/0001564590-18-019939-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018020796/0001564590-18-020796-index.htm |
| 2018-08-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1080709/000156459018022365/0001564590-18-022365-index.htm |
| 2018-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018023519/0001564590-18-023519-index.htm |
| 2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018023845/0001564590-18-023845-index.htm |
| 2018-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018023927/0001564590-18-023927-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018027994/0001564590-18-027994-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459018028552/0001564590-18-028552-index.htm |
| 2018-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018029645/0001564590-18-029645-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018030709/0001564590-18-030709-index.htm |
| 2018-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459018030994/0001564590-18-030994-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019000292/0001564590-19-000292-index.htm |
| 2019-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019000516/0001564590-19-000516-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019001108/0001564590-19-001108-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019004455/0001564590-19-004455-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1080709/000156459019005441/0001564590-19-005441-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1080709/000156459019013997/0001564590-19-013997-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1080709/000156459019014001/0001564590-19-014001-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019017181/0001564590-19-017181-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459019018015/0001564590-19-018015-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019022576/0001564590-19-022576-index.htm |
| 2019-06-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1080709/000156459019022586/0001564590-19-022586-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019030049/0001564590-19-030049-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459019030945/0001564590-19-030945-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459019041731/0001564590-19-041731-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459019042020/0001564590-19-042020-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020000781/0001564590-20-000781-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020000964/0001564590-20-000964-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020006772/0001564590-20-006772-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1080709/000156459020007399/0001564590-20-007399-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020014775/0001564590-20-014775-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020022892/0001564590-20-022892-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459020022995/0001564590-20-022995-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020027028/0001564590-20-027028-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020028645/0001564590-20-028645-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/0001564590-20-029543-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/0001564590-20-029970-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/0001564590-20-029972-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/0001564590-20-029977-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/0001564590-20-029978-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/0001564590-20-029982-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/0001564590-20-029984-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/0001564590-20-029985-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/0001564590-20-029986-index.htm |
| 2020-06-19 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/0001564590-20-029989-index.htm |
| 2020-06-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/0001564590-20-029991-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/0001564590-20-036786-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/0001564590-20-036902-index.htm |
| 2020-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/0001564590-20-044366-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/0001564590-20-047516-index.htm |
| 2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1080709/000156459020048172/0001564590-20-048172-index.htm |
| 2019-03-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1080709/999999999719001645/9999999997-19-001645-index.htm |
Arena Pharmaceuticals, Inc (ARNA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arena Pharmaceuticals, Inc (ARNA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 19%Institutional Ownership: 9189%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-09-09 | Aurentz Vincent | Executive VP and CBO | Sell | 20,328.00 | 51.23 | 1,041,501.01 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049105/0001209191-19-049105-index.htm |
| 2020-02-05 | Aurentz Vincent | Executive VP and CBO | Sell | 9,000.00 | 50.00 | 450,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120007535/0001209191-20-007535-index.htm |
| 2020-06-02 | Aurentz Vincent | Executive VP and CBO | Sell | 25,000.00 | 65.00 | 1,625,022.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034544/0001209191-20-034544-index.htm |
| 2020-07-15 | Christopher Cabell | EVP, Head of R&D, and CMO | Sell | 13,000.00 | 68.00 | 884,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120042910/0001209191-20-042910-index.htm |
| 2019-01-07 | Preston Klassen | EVP and CMO | Sell | 400.00 | 42.32 | 16,927.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002953/0001209191-19-002953-index.htm |
| 2019-01-08 | Preston Klassen | EVP and CMO | Sell | 3,000.00 | 44.00 | 132,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002953/0001209191-19-002953-index.htm |
| 2019-11-13 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | 4,429.00 | 45.83 | 202,999.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119058166/0001209191-19-058166-index.htm |
| 2020-08-04 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | 22,575.00 | 63.58 | 1,435,298.18 | 0.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120045483/0001209191-20-045483-index.htm |
| 2020-06-02 | Aurentz Vincent | Executive VP and CBO | Buy | 10,000.00 | 17.10 | 171,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034544/0001209191-20-034544-index.htm |
| 2018-06-13 | Tina Susan Nova | Director | Buy | 3,050.00 | 11,476.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038079/0001209191-18-038079-index.htm | ||
| 2019-03-07 | Tina Susan Nova | Director | Sell | 1,200.00 | 45.99 | 55,182.60 | 11,476.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119018252/0001209191-19-018252-index.htm |
| 2018-06-13 | RANDALL E WOODS | Director | Buy | 3,050.00 | 11,576.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038083/0001209191-18-038083-index.htm | ||
| 2019-03-07 | Tina Susan Nova | Director | Buy | 1,200.00 | 40.10 | 48,120.00 | 12,676.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119018252/0001209191-19-018252-index.htm |
| 2020-07-15 | Christopher Cabell | EVP, Head of R&D, and CMO | Buy | 13,000.00 | 26.28 | 341,640.00 | 13,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120042910/0001209191-20-042910-index.htm |
| 2020-06-12 | Katharine Knobil | Director | Buy | 1,223.00 | 1,308.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037101/0001209191-20-037101-index.htm | ||
| 2019-06-13 | Tina Susan Nova | Director | Buy | 2,654.00 | 14,130.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037501/0001209191-19-037501-index.htm | ||
| 2020-05-22 | Amit Munshi | President and CEO | Sell | 13,931.00 | 58.61 | 816,461.08 | 14,212.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2019-06-13 | RANDALL E WOODS | Director | Buy | 2,654.00 | 14,230.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037512/0001209191-19-037512-index.htm | ||
| 2019-11-12 | RANDALL E WOODS | Director | Sell | 3,046.00 | 46.73 | 142,339.58 | 14,230.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119056490/0001209191-19-056490-index.htm |
| 2020-02-13 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 2,472.00 | 32.50 | 80,340.00 | 15,339.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009837/0001209191-20-009837-index.htm |
| 2020-06-03 | Amit Munshi | President and CEO | Buy | 8,139.00 | 14.60 | 118,829.40 | 15,889.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2019-10-14 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 6,300.00 | 15,990.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053339/0001209191-19-053339-index.htm | ||
| 2019-01-07 | Preston Klassen | EVP and CMO | Buy | 16,000.00 | 15.10 | 241,600.00 | 16,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002953/0001209191-19-002953-index.htm |
| 2020-06-12 | Tina Susan Nova | Director | Buy | 2,446.00 | 16,576.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037107/0001209191-20-037107-index.htm | ||
| 2020-08-26 | Tina Susan Nova | Director | Sell | 17,300.00 | 67.94 | 1,175,303.18 | 16,576.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048662/0001209191-20-048662-index.htm |
| 2018-07-06 | KIERAN GALLAHUE | Director | Buy | 1,674.00 | 1,674.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118042143/0001209191-18-042143-index.htm | ||
| 2019-11-12 | RANDALL E WOODS | Director | Buy | 3,046.00 | 32.50 | 98,995.00 | 17,276.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119056490/0001209191-19-056490-index.htm |
| 2020-02-27 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 7,970.00 | 14.90 | 118,753.00 | 17,437.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120014125/0001209191-20-014125-index.htm |
| 2020-08-26 | Tina Susan Nova | Director | Buy | 1,200.00 | 14.90 | 17,880.00 | 17,776.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048662/0001209191-20-048662-index.htm |
| 2018-12-14 | Manmeet Singh Soni | Director | Buy | 1,825.00 | 1,825.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118062940/0001209191-18-062940-index.htm | ||
| 2019-10-14 | Amit Munshi | President and CEO | Buy | 11,700.00 | 19,450.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053332/0001209191-19-053332-index.htm | ||
| 2018-04-16 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 1,400.00 | 35.81 | 50,134.98 | 19,690.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118025436/0001209191-18-025436-index.htm |
| 2018-08-15 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 3,943.00 | 36.69 | 144,676.16 | 19,690.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118047467/0001209191-18-047467-index.htm |
| 2019-02-01 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 1,500.00 | 46.10 | 69,150.00 | 19,690.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119007127/0001209191-19-007127-index.htm |
| 2019-09-09 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 21,200.00 | 50.48 | 1,070,086.96 | 19,947.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2020-06-02 | Aurentz Vincent | Executive VP and CBO | Buy | 10,000.00 | 14.60 | 146,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034544/0001209191-20-034544-index.htm |
| 2020-02-13 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 4,964.00 | 37.20 | 184,660.80 | 20,303.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009837/0001209191-20-009837-index.htm |
| 2019-09-09 | Aurentz Vincent | Executive VP and CBO | Sell | 44,672.00 | 50.48 | 2,255,198.91 | 20,328.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049105/0001209191-19-049105-index.htm |
| 2018-04-16 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 7,700.00 | 35.00 | 269,466.89 | 21,090.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118025436/0001209191-18-025436-index.htm |
| 2019-02-01 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 1,500.00 | 40.10 | 60,150.00 | 21,190.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119007127/0001209191-19-007127-index.htm |
| 2020-08-26 | Tina Susan Nova | Director | Buy | 3,600.00 | 12.70 | 45,720.00 | 21,376.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048662/0001209191-20-048662-index.htm |
| 2019-09-10 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 12,627.00 | 15.50 | 195,718.50 | 22,317.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2020-08-04 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | 7,425.00 | 62.63 | 465,047.06 | 22,575.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120045483/0001209191-20-045483-index.htm |
| 2020-02-13 | Amit Munshi | President and CEO | Buy | 15,200.00 | 14.60 | 221,920.00 | 22,950.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009831/0001209191-20-009831-index.htm |
| 2019-09-09 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 3,274.00 | 32.50 | 106,405.00 | 22,964.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2018-08-15 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 25,062.00 | 35.90 | 899,828.55 | 23,633.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118047467/0001209191-18-047467-index.htm |
| 2019-09-09 | Aurentz Vincent | Executive VP and CBO | Buy | 25,000.00 | 17.10 | 427,500.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049105/0001209191-19-049105-index.htm |
| 2020-06-02 | Aurentz Vincent | Executive VP and CBO | Buy | 5,000.00 | 35.60 | 178,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034544/0001209191-20-034544-index.htm |
| 2020-06-03 | Amit Munshi | President and CEO | Sell | 20,028.00 | 68.61 | 1,374,213.21 | 25,712.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2020-05-22 | Amit Munshi | President and CEO | Sell | 9,017.00 | 57.52 | 518,662.35 | 28,143.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2019-09-09 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 5,810.00 | 17.90 | 103,999.00 | 28,774.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2018-04-16 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 20,901.00 | 34.33 | 717,456.09 | 28,790.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118025436/0001209191-18-025436-index.htm |
| 2019-01-08 | Preston Klassen | EVP and CMO | Buy | 3,000.00 | 15.10 | 45,300.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002953/0001209191-19-002953-index.htm |
| 2020-08-04 | Robert Lisicki | EVP, Chief Commercial Officer | Buy | 30,000.00 | 40.95 | 1,228,500.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120045483/0001209191-20-045483-index.htm |
| 2018-06-13 | GARRY ARTHUR NEIL | Director | Buy | 3,050.00 | 3,050.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038076/0001209191-18-038076-index.htm | ||
| 2018-06-13 | Jayson Donald Alexander Dallas | Director | Buy | 3,050.00 | 3,050.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038061/0001209191-18-038061-index.htm | ||
| 2018-06-13 | Jennifer Jarrett | Director | Buy | 3,050.00 | 3,050.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038068/0001209191-18-038068-index.htm | ||
| 2018-06-13 | OLIVER FETZER | Director | Buy | 3,050.00 | 3,050.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118038064/0001209191-18-038064-index.htm | ||
| 2020-08-26 | Tina Susan Nova | Director | Buy | 12,500.00 | 20.00 | 250,000.00 | 33,876.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048662/0001209191-20-048662-index.htm |
| 2020-02-13 | Kevin Robert Lind | Executive VP and CFO | Sell | 4,500.00 | 55.00 | 247,500.00 | 3,457.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009834/0001209191-20-009834-index.htm |
| 2018-04-16 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 15,001.00 | 17.90 | 268,517.90 | 34,691.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118025436/0001209191-18-025436-index.htm |
| 2019-09-09 | Aurentz Vincent | Executive VP and CBO | Buy | 10,000.00 | 14.60 | 146,000.00 | 35,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049105/0001209191-19-049105-index.htm |
| 2020-05-22 | Amit Munshi | President and CEO | Sell | 5,390.00 | 56.67 | 305,468.01 | 37,160.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2020-06-12 | Katharine Knobil | Director | Buy | 2,446.00 | 3,754.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037101/0001209191-20-037101-index.htm | ||
| 2019-01-07 | Preston Klassen | EVP and CMO | Sell | 15,600.00 | 41.68 | 650,139.36 | 400.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119002953/0001209191-19-002953-index.htm |
| 2019-09-09 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 12,373.00 | 15.50 | 191,781.50 | 41,147.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2019-06-14 | Jayson Donald Alexander Dallas | Director | Sell | 170.00 | 56.51 | 9,606.39 | 4,179.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037485/0001209191-19-037485-index.htm |
| 2019-06-14 | OLIVER FETZER | Director | Sell | 30.00 | 56.64 | 1,699.20 | 4,179.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037487/0001209191-19-037487-index.htm |
| 2019-06-14 | OLIVER FETZER | Director | Sell | 1,495.00 | 55.88 | 83,539.25 | 4,209.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037487/0001209191-19-037487-index.htm |
| 2020-05-22 | Amit Munshi | President and CEO | Buy | 34,800.00 | 14.60 | 508,080.00 | 42,550.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2019-06-14 | Jayson Donald Alexander Dallas | Director | Sell | 1,355.00 | 55.82 | 75,633.93 | 4,349.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037485/0001209191-19-037485-index.htm |
| 2020-06-03 | Amit Munshi | President and CEO | Sell | 12,010.00 | 67.36 | 809,009.21 | 45,740.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2018-07-06 | KIERAN GALLAHUE | Director | Buy | 3,070.00 | 4,744.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118042143/0001209191-18-042143-index.htm | ||
| 2018-08-15 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 29,005.00 | 18.10 | 524,990.50 | 48,695.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118047467/0001209191-18-047467-index.htm |
| 2018-04-16 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Buy | 15,000.00 | 18.10 | 271,500.00 | 49,691.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919118025436/0001209191-18-025436-index.htm |
| 2019-06-14 | Manmeet Singh Soni | Director | Sell | 133.00 | 56.51 | 7,516.04 | 5,087.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037506/0001209191-19-037506-index.htm |
| 2019-06-14 | Manmeet Singh Soni | Director | Sell | 1,084.00 | 55.82 | 60,505.84 | 5,220.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037506/0001209191-19-037506-index.htm |
| 2019-06-13 | GARRY ARTHUR NEIL | Director | Buy | 2,654.00 | 5,704.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037495/0001209191-19-037495-index.htm | ||
| 2019-06-13 | Jayson Donald Alexander Dallas | Director | Buy | 2,654.00 | 5,704.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037485/0001209191-19-037485-index.htm | ||
| 2019-06-13 | Jennifer Jarrett | Director | Buy | 2,654.00 | 5,704.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037492/0001209191-19-037492-index.htm | ||
| 2019-06-13 | OLIVER FETZER | Director | Buy | 2,654.00 | 5,704.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037487/0001209191-19-037487-index.htm | ||
| 2020-05-21 | Amit Munshi | President and CEO | Buy | 50,000.00 | 14.60 | 730,000.00 | 57,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2020-06-02 | Amit Munshi | President and CEO | Buy | 50,000.00 | 14.60 | 730,000.00 | 57,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2020-06-03 | Amit Munshi | President and CEO | Buy | 41,861.00 | 15.50 | 648,845.50 | 57,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2020-08-28 | Amit Munshi | President and CEO | Buy | 50,000.00 | 15.50 | 775,000.00 | 57,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048864/0001209191-20-048864-index.htm |
| 2020-08-31 | Amit Munshi | President and CEO | Buy | 50,000.00 | 15.50 | 775,000.00 | 57,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048864/0001209191-20-048864-index.htm |
| 2020-06-17 | Manmeet Singh Soni | Director | Sell | 304.00 | 62.74 | 19,072.96 | 5,902.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037654/0001209191-20-037654-index.htm |
| 2020-02-13 | Kevin Robert Lind | Executive VP and CFO | Buy | 2,500.00 | 19.40 | 48,500.00 | 5,957.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009834/0001209191-20-009834-index.htm |
| 2020-06-15 | Manmeet Singh Soni | Director | Sell | 1,327.00 | 60.12 | 79,779.24 | 6,206.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037151/0001209191-20-037151-index.htm |
| 2019-10-14 | Preston Klassen | EVP and CMO | Buy | 6,300.00 | 6,300.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053336/0001209191-19-053336-index.htm | ||
| 2019-10-14 | Robert Lisicki | EVP, Chief Commercial Officer | Buy | 6,300.00 | 6,300.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053337/0001209191-19-053337-index.htm | ||
| 2019-06-13 | Manmeet Singh Soni | Director | Buy | 2,654.00 | 6,304.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037506/0001209191-19-037506-index.htm | ||
| 2019-09-09 | Aurentz Vincent | Executive VP and CBO | Buy | 30,000.00 | 35.60 | 1,068,000.00 | 65,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049105/0001209191-19-049105-index.htm |
| 2019-10-14 | Kevin Robert Lind | Executive VP and CFO | Buy | 6,300.00 | 6,548.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053333/0001209191-19-053333-index.htm | ||
| 2020-06-12 | Jayson Donald Alexander Dallas | Director | Buy | 2,446.00 | 6,625.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037102/0001209191-20-037102-index.htm | ||
| 2020-06-12 | OLIVER FETZER | Director | Buy | 2,446.00 | 6,625.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037103/0001209191-20-037103-index.htm | ||
| 2019-06-13 | KIERAN GALLAHUE | Director | Buy | 2,654.00 | 7,398.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119037490/0001209191-19-037490-index.htm | ||
| 2020-06-12 | Manmeet Singh Soni | Director | Buy | 2,446.00 | 7,533.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037151/0001209191-20-037151-index.htm | ||
| 2020-02-05 | Amit Munshi | President and CEO | Sell | 7,129.00 | 50.00 | 356,450.00 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120007531/0001209191-20-007531-index.htm |
| 2020-02-13 | Amit Munshi | President and CEO | Sell | 15,200.00 | 55.00 | 836,000.00 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009831/0001209191-20-009831-index.htm |
| 2020-05-21 | Amit Munshi | President and CEO | Sell | 50,000.00 | 55.00 | 2,750,000.00 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2020-05-22 | Amit Munshi | President and CEO | Sell | 6,462.00 | 59.12 | 382,016.64 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120031876/0001209191-20-031876-index.htm |
| 2020-06-02 | Amit Munshi | President and CEO | Sell | 50,000.00 | 65.00 | 3,250,000.00 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2020-06-03 | Amit Munshi | President and CEO | Sell | 17,962.00 | 69.26 | 1,244,013.99 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120034542/0001209191-20-034542-index.htm |
| 2020-08-28 | Amit Munshi | President and CEO | Sell | 50,000.00 | 70.00 | 3,500,000.00 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048864/0001209191-20-048864-index.htm |
| 2020-08-31 | Amit Munshi | President and CEO | Sell | 50,000.00 | 70.10 | 3,505,035.00 | 7,750.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120048864/0001209191-20-048864-index.htm |
| 2020-02-13 | Kevin Robert Lind | Executive VP and CFO | Buy | 2,000.00 | 35.60 | 71,200.00 | 7,957.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009834/0001209191-20-009834-index.htm |
| 2020-06-12 | GARRY ARTHUR NEIL | Director | Buy | 2,446.00 | 8,150.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037106/0001209191-20-037106-index.htm | ||
| 2020-06-12 | Jennifer Jarrett | Director | Buy | 2,446.00 | 8,150.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037105/0001209191-20-037105-index.htm | ||
| 2019-10-14 | Aurentz Vincent | Executive VP and CBO | Buy | 9,000.00 | 9,000.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119053335/0001209191-19-053335-index.htm | ||
| 2020-02-13 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 10,836.00 | 55.00 | 595,980.00 | 9,467.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120009837/0001209191-20-009837-index.htm |
| 2019-09-09 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 10,257.00 | 51.23 | 525,428.16 | 9,690.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2019-09-10 | STEVEN W SPECTOR | EVP, General Counsel & Sec | Sell | 12,627.00 | 50.28 | 634,872.93 | 9,690.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919119049104/0001209191-19-049104-index.htm |
| 2020-06-12 | KIERAN GALLAHUE | Director | Buy | 2,446.00 | 9,844.00 | https://www.sec.gov/Archives/edgar/data/1080709/000120919120037104/0001209191-20-037104-index.htm |